Research map: Pharmacologic and Non-Pharmacologic Interventions for Hypothalamic Obesity: An Updated Review

Back to the article

Papers in this map

  1. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. · George A. Bray · 1979 · 1151 citations · Cited by this paper
  2. Cross-Sector Policies for Achieving Equitable Obesity Prevention and Food Security: A Review of Real-World Actions · 2026 · Related
  3. The descriptive epidemiology of craniopharyngioma · Greta R. Bunin · 1998 · 691 citations · Cited by this paper
  4. Emotional Eating and Obesity: An Update and New Insights · 2025 · Related
  5. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up · Hermann Lothar Muller · 2011 · 304 citations · Cited by this paper
  6. Intersection between Eating Disorders and Obesity in Youth: Implications for Treatment · 2025 · Related
  7. Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial · Robert H. Lustig · 2003 · 301 citations · Cited by this paper
  8. The Role of Fathers in the Intergenerational Transmission of Obesity · 2026 · Related
  9. High prevalence of long‐term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma · Alberto M. Pereira · 2004 · 226 citations · Cited by this paper
  10. Adult Growth Hormone Deficiency and Metabolic Dysfunction-Associated Steatotic Liver Disease · 2026 · Related
  11. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial · Arne Vernon Astrup · 2008 · 195 citations · Cited by this paper
  12. Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat · 2026 · Related
  13. Discrete BDNF Neurons in the Paraventricular Hypothalamus Control Feeding and Energy Expenditure · Juan Ji An · 2015 · 168 citations · Cited by this paper
  14. Weight Loss Effect of Lisdexamfetamine in Children with Severe Obesity: A Case Series · 2025 · Related
  15. Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy · JillK Hamilton · 2011 · 112 citations · Cited by this paper
  16. Morbidity and mortality in patients with craniopharyngioma after surgery · Rachel Katherine Crowley · 2010 · 108 citations · Cited by this paper
  17. Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity · Christian Ludwig Roth · 2015 · 97 citations · Cited by this paper
  18. A phase 3 randomized clinical trial using a o nce‐weekly glucagon‐like peptide‐1 receptor agonist in adolescents and young adults with hypothalamic obesity · Christian Ludwig Roth · 2020 · 88 citations · Cited by this paper
  19. Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial · Christian Ludwig Roth · 2024 · 72 citations · Cited by this paper
  20. Treatment of Acquired Hypothalamic Obesity: Now and the Future · Paul Dimitri · 2022 · 71 citations · Cited by this paper
  21. Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity · Clinton Elfers · 2011 · 65 citations · Cited by this paper
  22. Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma · Anika Hoffmann · 2015 · 62 citations · Cited by this paper
  23. Weight Loss Produced by Tesofensine in Patients With Parkinson's or Alzheimer's Disease · Arne Vernon Astrup · 2008 · 59 citations · Cited by this paper
  24. Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series · Christian Denzer · 2019 · 56 citations · Cited by this paper
  25. Hypothalamic obesity: from basic mechanisms to clinical perspectives · Jesús Argente · 2024 · 53 citations · Cited by this paper
  26. Treatment of Hypothalamic Obesity with Caffeine and Ephedrine · Frank L. Greenway · 2008 · 52 citations · Cited by this paper
  27. The effects of glucagon‐like peptide (GLP)‐1 receptor agonists on weight and glycaemic control in Prader–Willi syndrome: A systematic review · Nicholas Beng Hui Ng · 2021 · 44 citations · Cited by this paper
  28. Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity · Kim Huynh · 2022 · 41 citations · Cited by this paper
  29. Diazoxide in Children With Obesity After Hypothalamic-Pituitary Lesions: A Randomized, Placebo-Controlled Trial · Raja Brauner · 2016 · 38 citations · Cited by this paper
  30. Hypothalamic Obesity: 4 Years of the International Registry of Hypothalamic Obesity Disorders · Susan Rogers Rose · 2018 · 35 citations · Cited by this paper
  31. MRI measures of hypothalamic injury are associated with glucagon‐like peptide‐1 receptor agonist treatment response in people with hypothalamic obesity · Francisco A. Perez · 2021 · 30 citations · Cited by this paper
  32. Dextroamphetamine Treatment in Children With Hypothalamic Obesity · Jiska van Schaïk · 2022 · 30 citations · Cited by this paper
  33. Weight loss with glucagon‐like peptide‐1 receptor agonists in Bardet‐Biedl syndrome · Shawg Ganawa · 2022 · 25 citations · Cited by this paper
  34. Semaglutide treatment of hypothalamic obesity – a real-life data study · Mathilde Svendstrup · 2024 · 23 citations · Cited by this paper
  35. Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity · Hanneke Margo van Santen · 2025 · 20 citations · Cited by this paper
  36. Feasibility, safety, and efficacy of dietary or lifestyle interventions for hypothalamic obesity: A systematic review · Ichelle M. A. A. van Roessel · 2024 · 18 citations · Cited by this paper
  37. Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma · So Yoon Jung · 2017 · 15 citations · Cited by this paper
  38. Five-Year Changes in Weight and Diabetes Status After Bariatric Surgery for Craniopharyngioma-Related Hypothalamic Obesity: a Case–Control Study · Pauline Faucher · 2022 · 14 citations · Cited by this paper
  39. Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life · Erlend Gjersdal · 2025 · 13 citations · Cited by this paper

Source: OpenAlex (CC0)